What You Should Know:
– COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer…
Continue Reading
What You Should Know:
Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, announced the commercial launch of the Tapestri® Single-cell MRD (scMRD) AML Multiomics Assay.The company designed the scMRD AML Multiomics Assay to bring…
Continue Reading
Self-pay healthcare marketplace Sesame announced its teaming up with Costco to provide the wholesaler’s members virtual and in-person healthcare at a discounted price through Sesame’s network of providers. Sesame’s direct-payment healthcare marketplace provides consumers access…
Continue Reading
Publicly traded telemedicine company LifeMD announced it is partnering with women’s health-focused specialty pharmaceutical company ASCEND Therapeutics to improve access to EstroGel, a hormone therapy for postmenopausal women. The FDA-approved gel is used to alleviate…
Continue Reading
What You Should Know:
A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression. By analyzing the brain activity of patients undergoing deep brain stimulation (DBS),…
Continue Reading
RefleXion Medical will feature its groundbreaking RefleXion X1 with SCINTIX biology-guided radiotherapy at ASTRO 2023. Researchers will present 19 scientific findings supporting the effectiveness of SCINTIX therapy, highlighting its precision in treating moving targets,…
Continue Reading
What You Should Know: Today, Rev1 Ventures, the venture studio that helps entrepreneurs and corporations accelerate innovation, Nationwide Children’s Hospital, and The Ohio State University announce expanded support for life sciences companies with the launch of Rev1 Catalyst…
Continue Reading
Background: Increased smartphone ownership has led to the development of mobile smoking cessation programs. Although the related body of evidence, gathered through the conduct of randomized controlled trials (RCTs), has grown in quality and…
Continue Reading
Digital health company Oto is to work with clinical trial start-up Lindus Health to launch a fully remote, digital trial that aims to increase patients’ access to tinnitus therapy.The trial will see 198 adult…
Continue Reading
A study conducted by The University of Texas MD Anderson Cancer Center recommends intensity-modulated radiation therapy (IMRT) as the preferred treatment for locally advanced non-small cell lung cancer (NSCLC). IMRT significantly reduces lung and…
Continue Reading
